AmeriPath Term Loan Breaks Above Par

AmeriPath's $203.5 million term loan broke in the secondary market at 101 1/4 last week.

  • 20 Jan 2006
Email a colleague
Request a PDF

AmeriPath's $203.5 million term loan broke in the secondary market at 101 1/4 last week. One trader said it was a popular name that was oversubscribed. Wachovia Bank, Citigroup and Deutsche Bank lead the deal, which is priced at LIBOR plus 2%. Original price talk on the loan was LIBOR plus 2 1/4% (CIN, 11/21). The credit also consists of a $95 million revolver. The deal backs AmeriPath's merger with Specialty Laboratories. Welsh, Carson, Anderson and Stowe is AmeriPath's equity sponsor.

Ameripath provides testing and information services to physicians in the detection, diagnosis and treatment of medical conditions. David Redmond, executive v.p. and cfo, did not return calls.

  • 20 Jan 2006

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Bank of America Merrill Lynch (BAML) 3,136 9 12.62
2 Citi 2,562 6 10.31
3 Goldman Sachs 2,150 3 8.65
4 Credit Suisse 1,822 6 7.33
5 Societe Generale 1,814 4 7.30

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 22 May 2017
1 Citi 41,255.30 117 12.99%
2 Bank of America Merrill Lynch 37,631.92 109 11.85%
3 Wells Fargo Securities 32,082.26 89 10.11%
4 JPMorgan 20,969.41 64 6.60%
5 Credit Suisse 16,754.47 44 5.28%